BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 17100604)

  • 1. Cervical cancer and human papillomaviruses: inactivation of retinoblastoma and other tumor suppressor pathways.
    Jones EE; Wells SI
    Curr Mol Med; 2006 Nov; 6(7):795-808. PubMed ID: 17100604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Papillomavirus E6 and E7 proteins and their cellular targets.
    Wise-Draper TM; Wells SI
    Front Biosci; 2008 Jan; 13():1003-17. PubMed ID: 17981607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells.
    Hu G; Liu W; Hanania EG; Fu S; Wang T; Deisseroth AB
    Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways.
    Goodwin EC; DiMaio D
    Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12513-8. PubMed ID: 11070078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Human papillomaviruses, cell cycle and cervical cancer].
    Mougin C; Humbey O; Gay C; Riethmuller D
    J Gynecol Obstet Biol Reprod (Paris); 2000 Feb; 29(1):13-20. PubMed ID: 10675829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular mechanism of carcinogenesis by human papillomavirus-16.
    Ishiji T
    J Dermatol; 2000 Feb; 27(2):73-86. PubMed ID: 10721654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanisms of cervical carcinogenesis by high-risk human papillomaviruses: novel functions of E6 and E7 oncoproteins.
    Yugawa T; Kiyono T
    Rev Med Virol; 2009 Mar; 19(2):97-113. PubMed ID: 19156753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HPV: Molecular pathways and targets.
    Gupta S; Kumar P; Das BC
    Curr Probl Cancer; 2018; 42(2):161-174. PubMed ID: 29706467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanisms of transformation by the human papillomaviruses.
    Howley PM; Münger K; Werness BA; Phelps WC; Schlegel R
    Princess Takamatsu Symp; 1989; 20():199-206. PubMed ID: 2562182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular targets of the oncoproteins encoded by the cancer associated human papillomaviruses.
    Howley PM; Münger K; Romanczuk H; Scheffner M; Huibregtse JM
    Princess Takamatsu Symp; 1991; 22():239-48. PubMed ID: 1668886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tanshinone IIA inhibits viral oncogene expression leading to apoptosis and inhibition of cervical cancer.
    Munagala R; Aqil F; Jeyabalan J; Gupta RC
    Cancer Lett; 2015 Jan; 356(2 Pt B):536-46. PubMed ID: 25304375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human papillomaviruses.
    zur Hausen H; de Villiers EM
    Annu Rev Microbiol; 1994; 48():427-47. PubMed ID: 7826013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular and molecular alterations in human epithelial cells transformed by recombinant human papillomavirus DNA.
    DiPaolo JA; Popescu NC; Alvarez L; Woodworth CD
    Crit Rev Oncog; 1993; 4(4):337-60. PubMed ID: 8394744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signaling pathways in HPV-associated cancers and therapeutic implications.
    Chen J
    Rev Med Virol; 2015 Mar; 25 Suppl 1():24-53. PubMed ID: 25752815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human papillomavirus proteins as prospective therapeutic targets.
    Pang CL; Thierry F
    Microb Pathog; 2013 May; 58():55-65. PubMed ID: 23164805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of human papillomaviruses in oncogenesis.
    Mighty KK; Laimins LA
    Recent Results Cancer Res; 2014; 193():135-48. PubMed ID: 24008297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific down-modulation of Notch1 signaling in cervical cancer cells is required for sustained HPV-E6/E7 expression and late steps of malignant transformation.
    Talora C; Sgroi DC; Crum CP; Dotto GP
    Genes Dev; 2002 Sep; 16(17):2252-63. PubMed ID: 12208848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between p14(ARF)/p16(INK4A) expression and HPV infection in uterine cervical cancer.
    Kanao H; Enomoto T; Ueda Y; Fujita M; Nakashima R; Ueno Y; Miyatake T; Yoshizaki T; Buzard GS; Kimura T; Yoshino K; Murata Y
    Cancer Lett; 2004 Sep; 213(1):31-7. PubMed ID: 15312681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human papillomavirus immortalization and transformation functions.
    Münger K; Howley PM
    Virus Res; 2002 Nov; 89(2):213-28. PubMed ID: 12445661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Both Rb and E7 are regulated by the ubiquitin proteasome pathway in HPV-containing cervical tumor cells.
    Wang J; Sampath A; Raychaudhuri P; Bagchi S
    Oncogene; 2001 Aug; 20(34):4740-9. PubMed ID: 11498796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.